Jonas Bergh

Researcher Next ID · RN-003521

Researcher · Biochemistry, Genetics and Molecular Biology

Stockholm, Sweden

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Cancer Genomics and Diagnostics

Advanced Breast Cancer Therapies

Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1910549
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw544
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(13)62422-8
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt303
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
JNCI Journal of the National Cancer Institute · 2006 · https://doi.org/10.1093/jnci/djj052

No projects listed.